• Home
• About Infarmed
  • Contacts
  • Meeting Center
    • Auditorium
    • Sala A
    • Rooms
• Human medicines
  • Portugal as Reference Member State
  • Submission of Marketing Authorisation Applications
  • Marketing authorisation
  • Statistics of Clinical Trials Assessed by Infarmed
  • Pharmacovigilance Bulletin
    • Index search
  • Availability of Medicines
  • Clinical trials
    • Clinical trial submission
    • Investigational medicinal product and auxiliary medicinal product
    • Clinical Trial Inspection
    • Clinical Trial Safety
    • Public information on Clinical Trials in Portugal
    • Clinical Trial evaluation statistics and indicators by Infarmed
    • Clinical Trials Coordination Group
      • VHP - PHASE 1 - Request validation
      • VHP - PHASE 2 - Request assessment
      • VHP - PHASE 3 - National phase
    • Clinical Trial Assessment in Portugal
    • EU reference regulations
    • Applicable national legislation
    • Accelerating Clinical Trials in the EU
• Medical devices
• Cosmetics
• Advanced search
• Privacy policy
• Cookies policy
• Contact us
• Frequently asked questions
  • Medical devices (MD) - FAQ
  • In vitro diagnostic medical devices(IVDDs) and applicable legislation
  • Vigilance System of Medical Devices
  • Regulatory and scientific advice (RSA)
• About bookmarks
• Links
• Site map
• Help
• About the website
• Our location
• Accessibility
• Press
• News